tm logo
IGALMI
Live/Registered
REGISTERED

on 12 Nov 2024

Last Applicant/ Owned by

555 Long Wharf Drive, 12th Floor

New Haven

CT

06516

Serial Number

90295383 filed on 03rd Nov 2020

Registration Number

7565627 registered on 12th Nov 2024

in the Principal Register

Correspondent Address

BRENDAN J HUGHES

BRENDAN J HUGHES COOLEY LLP

STE 700

WASHINGTON, DC 20004

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

IGALMI

Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with central nervous system disorders, namely, schizophrenia and bipolar disorder

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with central nervous system disorders, namely, schizophrenia and bipolar disorder


First Use Date in General

30th Jun 2022

First Use Date in Commerce

30th Jun 2022

Mark Details


Serial Number

No 90295383

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 332712-20000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Nov 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
12th Nov 2024REGISTERED-PRINCIPAL REGISTER
08th Oct 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08th Oct 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
22nd Aug 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Aug 2024STATEMENT OF USE PROCESSING COMPLETE
22nd Aug 2024SOU EXTENSION 5 GRANTED
21st Aug 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
26th Jun 2024USE AMENDMENT FILED
26th Jun 2024TEAS STATEMENT OF USE RECEIVED